242 related articles for article (PubMed ID: 3012705)
1. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
Fritz P; Adolph J; Bubeck B; Georgi P; zum Winkel K
Rofo; 1986 Jun; 144(6):689-95. PubMed ID: 3012705
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
Gulenchyn KY; Papoff W
Clin Nucl Med; 1987 Jan; 12(1):45-6. PubMed ID: 3815996
[TBL] [Abstract][Full Text] [Related]
3. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma.
Rudberg U; Udén R; Ahlbäck SO
Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
5. [MR tomography and bone marrow scintigraphy in the screening of skeletal metastases in patients with breast carcinoma].
Layer G; Rieker O; Dörr D; Schnakenberg D; Steudel A; Reiser M
Rofo; 1994 May; 160(5):448-52. PubMed ID: 8173054
[TBL] [Abstract][Full Text] [Related]
6. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-nanocolloid bone marrow scintigraphy in prostatic cancer.
Haddock G; Gray HW; McKillop JH; Bessent RG; Kirk D
Br J Urol; 1989 May; 63(5):497-502. PubMed ID: 2731008
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer.
Otsuka N; Fukunaga M; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A; Morita R
Eur J Nucl Med; 1985; 11(8):319-22. PubMed ID: 4076240
[TBL] [Abstract][Full Text] [Related]
9. [Significance of skeletal scintigraphy for oncological practice].
Kampmann H; Buchelt L
Rontgenblatter; 1983 Oct; 36(10):342-51. PubMed ID: 6227979
[TBL] [Abstract][Full Text] [Related]
10. [Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases].
Hotze A; Löw A; Mahlstedt J; Wolf F
Rofo; 1984 Jun; 140(6):717-23. PubMed ID: 6234628
[TBL] [Abstract][Full Text] [Related]
11. [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow].
Reske SN; Karstens JH; Glöckner WM; Ammon J; Büll U
Rofo; 1990 Jan; 152(1):60-6. PubMed ID: 2154012
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of the bone marrow imaging agent 99Tcm-phytate in the detection of bone metastases.
Chang CP; Liu RS; Yu SM; Wynchank S; Chu LS; Shiau HY; Cheng TC
Nucl Med Commun; 1996 Dec; 17(12):1030-4. PubMed ID: 9004298
[TBL] [Abstract][Full Text] [Related]
13. [The usefulness of bone marrow scintigraphy in the detection of bone metastasis from prostatic cancer].
Otsuka N; Fukunaga M; Morita R; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A
Kaku Igaku; 1985 Feb; 22(2):169-76. PubMed ID: 3159922
[No Abstract] [Full Text] [Related]
14. High false negative rate of Tc-99m MDP whole-body bone scintigraphy in detecting skeletal metastases for patients with hepatoma.
Chen CY; Wu K; Lin WH; Lan TY; Wang SY; Sun JS; Weng PW; Yen RF; Yang RS
J Formos Med Assoc; 2012 Mar; 111(3):140-6. PubMed ID: 22423667
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
Lee KH; Chung JK; Choi CW; Jeong JM; Lee DS; Bang YJ; Lee MC; Kim NK; Koh CS
J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].
Bathmann J; Moser E
Radiologe; 1995 Jan; 35(1):8-14. PubMed ID: 7892445
[TBL] [Abstract][Full Text] [Related]
17. Bone and bone marrow scintigraphy in the diagnosis of neoplastic involvement of the skeletal system. A comparative analysis.
Sacchi S; Marietta M; Rinaldi G; Pantusa M; Romani F; Zaniol P; Torelli U
J Nucl Med Allied Sci; 1987; 31(3):255-60. PubMed ID: 3694273
[No Abstract] [Full Text] [Related]
18. Gallium-67 and technetium-99m-MDP scintigraphy for osseous involvement in lymphoma.
Van de Wiele C; Dierckx RA; Simons M; Noens L
J Nucl Med; 1996 Mar; 37(3):548. PubMed ID: 8772667
[No Abstract] [Full Text] [Related]
19. Bone marrow scintigraphy in prostatic carcinomas.
Bourgeois P; Malarme M; Van Franck R; Wauters G; Ferremans W
Nucl Med Commun; 1991 Jan; 12(1):35-45. PubMed ID: 2023692
[TBL] [Abstract][Full Text] [Related]
20. [NMR tomography in plasmacytoma].
Linden A; Gückel C; Widder R; Jungehülsing M; Diehl V; Schicha H
Rofo; 1992 Jan; 156(1):83-8. PubMed ID: 1733480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
